Combined use of immunotherapy in a patient with kidney carcinoma: nine years later
Abstract
Background: kidney cells carcinoma therapy is characterized by a poor response to adjuvant treatment.
Objective: to improve the free disease interval; global survive and quality of life.
Clinical case: a sixty three- year-old patient with a right kidney carcinoma was operated in August 1998. In May, 2002 he was diagnosed with abdominal adenopathies. On November, 2002 he was operated again because of adrenal metastases. On December, 2006 he began combined immunotherapy obtaining a complete response of him for the time being.
Conclusions: combined immunotherapy can be effective in the management of this type of tumor.
DeCS: CARCINOMA, RENAL CELL/therapy; DRUG THERAPY, COMBINATION; NEPHRECTOMY; MIDDLE AGED; CASE REPORTS.
Downloads
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/